A VEGF trap inhibits the beneficial effect of bFGF on vasoreactivity in corporal tissues of hypercholesterolemic rabbits

Journal of Sexual Medicine

Volumn 5, Issue 9, 2008, Pages 2069-2078

  Xie, Donghua ^a   Findley, Clarence M ^a   Greenfield, Jason M ^a   Pippen, Anne M ^a   Kontos, Christopher D ^a   Donatucci, Craig F ^a   Annex, Brian H ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Cytokine Growth Factors; Endothelium; Nitric Oxide

Indexed keywords

ADENOVIRUS VECTOR; BASIC FIBROBLAST GROWTH FACTOR; BETA GALACTOSIDASE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATE BUFFERED SALINE; PROTEIN KINASE B; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CHOLESTEROL INTAKE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; ERECTILE DYSFUNCTION; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASODILATATION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

EID: 51549119760     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00933.x     Document Type: Article

References (27)

1. Musicki B, Palese MA, Crone JK, Burnett AL. Phosphorylated endothelial nitric oxide synthase mediates vascular endothelial growth factor-induced penile erection. Biol Reprod 2004;70:282-9.
2. Azadzoi KM. Vasculogenic erectile dysfunction: Beyond the haemodynamic changes. BJU Int 2006;97:11-6.
3. Siroky MB, Azadzoi KM. Vasculogenic erectile dysfunction: Newer therapeutic strategies. J Urol 2003;170:S24-9; discussion S29-30.
4. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992;326:90-4.
5. Abdel Aziz MT, El-Asmer MF, Mostafa T, Mostafa S, Atta H, Aziz Wassef MA, Fouad H, Rashed L, Sabry D, Mahfouz S. Heme oxygenase vs. nitric oxide synthase in signaling mediating sildenafil citrate action. J Sex Med 2007;4:1098-107.
6. Magee TR, Kovanecz I, Davila HH, Ferrini MG, Cantini L, Vernet D, Zuniga FI, Rajfer J, Gonzalez-Cadavid NF. Antisense and short hairpin RNA (shRNA) constructs targeting PIN (Protein Inhibitor of NOS) ameliorate aging-related erectile dysfunction in the rat. J Sex Med 2007;4:633-43.
7. Xie D, Odronic SI, Wu F, Pippen AM, Donatucci CF, Annex BH. A mouse model of hypercholesterolemia-induced erectile dysfunction. J Sex Med 2007;4:898-907.
8. Wingard C, Fulton D, Husain S. Altered penile vascular reactivity and erection in the Zucker obese-diabetic rat. J Sex Med 2007;4:348-62.
9. Meurice T, Bauters C, Vallet B, Corseaux D, van Belle E, Hamon M, Dupuis B, Lablanche JM, Bertrand ME. bFGF restores endothelium-dependent responses of hypercholesterolemic rabbit thoracic aorta. Am J Physiol 1997;272:H613-7.
10. Xie D, Thompson MA, Pippen AM, Waters RE, Donatucci CF, Annex BH. Decreases in corporal VEGF expression precede vasoreactivity changes in cholesterol fed rabbits. J Urol 2005;173:1418-22.
11. Byrne RR, Henry GD, Rao DS, Huynh TT, Pippen AM, Annex BH, Hagen PO, Donatucci CF. Vascular endothelial growth factor restores corporal smooth muscle function in vitro. J Urol 2001;165:1310-5.
12. Henry GD, Byrne R, Hunyh TT, Abraham V, Annex BH, Hagen PO, Donatucci CF. Intracavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: A preliminary study. Int J Impot Res 2000;12:334-9.
13. Xie D, Pippen AM, Odronic SI, Annex BH, Donatucci CF. Intracavernosal basic fibroblast growth factor improves vasoreactivity in the hypercholesterolemic rabbit. J Sex Med 2006;3:223-32.
14. Hanai Y, Tokuda H, Yasuda E, Noda T, Ohta T, Takai S, Kozawa O. Up-regulation by zinc of FGF-2-induced VEGF release through enhancing p44/p42 MAP kinase activation in osteoblasts. Life Sci 2006;80:230-4.
15. Takai S, Tokuda H, Hanai Y, Harada A, Yasuda E, Matsushima-Nishiwaki R, Kato H, Ogura S, Ohta T, Kozawa O. Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/ c-Jun N-Terminal kinase in osteoblasts. J Bone Miner Res 2007;22:337-46.
16. Shi YH, Wang YX, Bingle L, Gong LH, Heng WJ, Li Y, Fang WG. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: Involvement of PI-3K/Akt and MEK1/ERK pathways. Pathology 2005;205:530-6.
17. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogensis via vascular endothelial growth factor receptors. Cancer Res 2000;60:203-12.
18. Schlessinger J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 2004;306:1506-7.
19. Milanini-Mongiat J, Pouyssegur J, Pages G. Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: Their implication in vascular endothelial growth factor gene transcription. J Biol Chem 2002;277:20631-9.
20. Pagès G, Milanini J, Richard DE, Berra E, GothiéE, Viñals F, Pouysségur J. Signaling angiogenesis via p42/p44 MAP kinase cascade. Ann N Y Acad Sci 2000;902:187-200.
21. Davis-Smyth T, Chen H, Park J, Presta LG, Ferrara N. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J 1996;15:4919-27.
22. Dubois NA, Kolpack LC, Wang R, Azizkhan RG, Bautch VL. Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas. Exp Cell Res 1991;196:302-13.
23. Huang J, Kontos CD. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem 2002;277:10760-6.
24. Dai Q, Silverstein AD, Davies MG, Hagen PO, Donatucci CF, Annex BH. Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits. J Urol 2003;170:664-8.
25. Wellmann S, Taube T, Paal K, Graf V Einsiedel H, Geilen W, Seifert G, Eckert C, Henze G, Seeger K. Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology. Clin Chem 2001;47:654-60.
26. Jonca F, Ortega N, Gleizes PE, Bertrand N, Plouet J. Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor. J Biol Chem 1997;272:24203-9.
27. Murphy PR, Limoges M, Dodd F, Boudreau RT, Too CK. Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Nb2 lymphoma cells. Endocrinology 2001;142:81-8.